Qualigen Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch QLGN and buy or sell other stocks, ETFs, and their options commission-free!About QLGN
Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS.
CEOMichael S. Poirier
CEOMichael S. Poirier
Employees46
Employees46
HeadquartersCarlsbad, California
HeadquartersCarlsbad, California
Founded2004
Founded2004
Employees46
Employees46
QLGN Key Statistics
Market cap199.76M
Market cap199.76M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume204.66K
Average volume204.66K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.12
52 Week high$3.12
52 Week low$0.171
52 Week low$0.171
Stock Snapshot
As of today, Qualigen Therapeutics(QLGN) shares are valued at $4.74. The company's market cap stands at 199.76M.
Qualigen Therapeutics(QLGN) stock opened on 2025-12-05 at —. The price climbed to — and dipped to —.
Qualigen Therapeutics(QLGN) shares are trading with a volume of 0, against a daily average of 204.66K.
In the last year, Qualigen Therapeutics(QLGN) shares hit a 52-week high of $3.12 and a 52-week low of $0.17.
In the last year, Qualigen Therapeutics(QLGN) shares hit a 52-week high of $3.12 and a 52-week low of $0.17.
People also own
Based on the portfolios of people who own QLGN. This list is generated using Robinhood data, and it’s not a recommendation.